Newsletters

Stay up-to-date with the latest news and articles written by our team of experts to assist medical device companies in navigating trends and challenges in regulatory affairs, quality management systems and clinical affairs.

Subscribe To AlvaMed's Newsletter

A monthly analysis of the medical device industry, quality and regulatory developments, and other useful information for industry professionals. (Contact details are never shared outside our organization.)
This field is for validation purposes and should be left unchanged.

To eQMS or Not: The Enduring Value of a Traditional QMS in a Digital Age

In today’s fast-paced, digital-first world, the allure of electronic Quality Management Systems (eQMS) is undeniable.

Impact of Medical Device Supply Chain Vulnerabilities on Public Health

The U.S. Food and Drug Administration (FDA) is focused on preventing and mitigating medical device

Rethinking eQMS: When a Traditional QMS Might be Right

An eQMS system, or electronic Quality Management System, is a software solution designed to automate

Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices

FDA recently issued a draft guidance document on “Protocol Deviations for Clinical Investigations of Drugs,

Evaluation of Sex-Specific and Gender-Specific Data in Medical Device Clinical Studies

On January 7, 2025, the FDA issued a draft guidance document on “Evaluation of Sex-Specific

FDA’s Quality Management Maturity Program

In an era where medical devices and pharmaceuticals are becoming increasingly complex, ensuring their safety

European Commission’s Guidance for Joint Clinical Assessments

In an effort to streamline and enhance the evaluation of health technologies across Europe, the

The Canadian Artificial Intelligence and Data Act

In an era where artificial intelligence (AI) is rapidly transforming industries and societal norms, Canada

Navigating the FDA QMSR Transition: Expert Guidance for a Seamless Journey

Are you ready for the FDA’s Quality Management System Regulation (QMSR) transition? The FDA’s new